High income vs Saint Vincent and the Grenadines: Immunization, Hib3
Immunization, Hib3 over time
- High income
- Saint Vincent and the Grenadines
How they compare
Saint Vincent and the Grenadines currently reports 99.0% against 93.2% in High income, a difference of 5.8%.
That makes Saint Vincent and the Grenadines's figure about 1.1 times High income's.
The two have swapped places 1 time across 22 shared years of data; in 2003 it was High income ahead.
High income ranks 4th and Saint Vincent and the Grenadines ranks 1st of 43 groups.
Saint Vincent and the Grenadines has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | High income | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.2% | 88.7% | 18.5% | Saint Vincent and the Grenadines |
| 2010s | 80.7% | 98.0% | 17.3% | Saint Vincent and the Grenadines |
| 2020s | 89.1% | 97.8% | 8.7% | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, High income or Saint Vincent and the Grenadines?
- Saint Vincent and the Grenadines, at 99.0% against 93.2% in High income as of 2024.
- What is the difference in immunization, hib3 between High income and Saint Vincent and the Grenadines?
- 5.8%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for High income and Saint Vincent and the Grenadines?
- 22 years are reported by both, from 2003 to 2024.
- How do High income and Saint Vincent and the Grenadines rank globally for immunization, hib3?
- High income ranks 4th and Saint Vincent and the Grenadines ranks 1st of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.